These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1973001)

  • 1. AIDS meeting: unexpected progress.
    Barinaga M
    Science; 1990 Jun; 248(4963):1596-7. PubMed ID: 1973001
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS, San Francisco.
    Gelmon K
    Lancet; 1990 Jun; 335(8705):1581-2. PubMed ID: 1972499
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV, AIDS, and zidovudine.
    Tedder RS; Semple MG; Tenant-Flowers M; Loveday C
    Lancet; 1992 Mar; 339(8796):805-6. PubMed ID: 1347820
    [No Abstract]   [Full Text] [Related]  

  • 4. Deficits in AIDS incidence.
    Segal M; Bacchetti P
    J Acquir Immune Defic Syndr (1988); 1990; 3(8):832-5. PubMed ID: 2366150
    [No Abstract]   [Full Text] [Related]  

  • 5. The Sixth International Conference on AIDS.
    J Am Osteopath Assoc; 1990 Aug; 90(8):676. PubMed ID: 2398022
    [No Abstract]   [Full Text] [Related]  

  • 6. ZDV resistance AIDS predictor.
    AIDS Patient Care; 1994 Jun; 8(3):164. PubMed ID: 11362141
    [No Abstract]   [Full Text] [Related]  

  • 7. Researchers look ahead to AIDS meeting.
    Barinaga M
    Science; 1990 Jun; 248(4960):1180-2. PubMed ID: 2349476
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV eliminated in AIDS patient with lymphoma.
    Am Fam Physician; 1990 Feb; 41(2):680. PubMed ID: 2301209
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.
    Land S; Terloar G; McPhee D; Birch C; Doherty R; Cooper D; Gust I
    J Infect Dis; 1990 Feb; 161(2):326-9. PubMed ID: 2299212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can combination therapy overcome drug resistance?
    Cohen J
    Science; 1993 May; 260(5112):1258. PubMed ID: 7684162
    [No Abstract]   [Full Text] [Related]  

  • 11. Commercial venture to speed up AIDS drug tests in California.
    Barinaga M
    Nature; 1988 May; 333(6170):196. PubMed ID: 3285222
    [No Abstract]   [Full Text] [Related]  

  • 12. Cessation of zidovudine therapy may lead to increased replication of HIV-1.
    Wainberg MA; Falutz J; Fanning M; Gill J; Gelmon K; Montaner JS; O'Shaughnessy M; Tsoukas C; Ruedy J
    JAMA; 1989 Feb; 261(6):865-6. PubMed ID: 2913381
    [No Abstract]   [Full Text] [Related]  

  • 13. Reprieve for AIDS conference.
    Lancet; 1990 May; 335(8697):1090. PubMed ID: 1970384
    [No Abstract]   [Full Text] [Related]  

  • 14. News from Washington AIDS meeting 1987.
    Benson E
    Aust Fam Physician; 1988 Jul; 17(7):553-4. PubMed ID: 2901258
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy.
    Burke DS; Redfield RR; Bjornson DC; Fowler AK; Oster CN
    N Engl J Med; 1989 Dec; 321(24):1682. PubMed ID: 2586573
    [No Abstract]   [Full Text] [Related]  

  • 16. Zidovudine.
    Freestone DS
    Lancet; 1992 Mar; 339(8793):626; author reply 627. PubMed ID: 1347138
    [No Abstract]   [Full Text] [Related]  

  • 17. Zidovudine-resistant variants of HIV-1 in brain.
    Di Stefano M; Norkrans G; Chiodi F; Hagberg L; Nielsen C; Svennerholm B
    Lancet; 1993 Oct; 342(8875):865. PubMed ID: 8104290
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS in 1988.
    Gallo RC; Montagnier L
    Sci Am; 1988 Oct; 259(4):41-8. PubMed ID: 3072672
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS conference: French not to attend.
    Coles P
    Nature; 1990 May; 345(6272):194. PubMed ID: 1970613
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival trends for patients with AIDS.
    Lemp GF; Payne SF; Neal D; Temelso T; Rutherford GW
    JAMA; 1990 Jan; 263(3):402-6. PubMed ID: 2294307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.